MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $71M
- YoY, 2025
- +47.4%
- 5-year CAGR
- +41.6%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $71M | +47.4% |
| 2024 | $48M | +38.3% |
| 2023 | $35M | +29.7% |
| 2022 | $27M | +17.0% |
| 2021 | $23M | +83.9% |
| 2020 | $13M | +106.8% |
| 2019 | $6.1M | — |